Aims & Scope
        Journal of Advanced Pharmaceutical Science and Technology (JAPST) publishes research advancing drug formulation, delivery systems, pharmaceutical analysis, and manufacturing technologies that bridge laboratory innovation to scalable pharmaceutical applications.
      
      
        Drug Formulation
        Delivery Systems
        Pharmaceutical Analysis
        Manufacturing Technology
        Pharmacokinetics
        Quality Control
      
    Core Research Domains
Drug Formulation & Development
- Formulation design and optimization
- Dosage form development (tablets, capsules, injectables, transdermals)
- Excipient selection and compatibility studies
- Stability testing and shelf-life prediction
- Scale-up and manufacturing process development
- Quality by Design (QbD) approaches
          Typical fit: Development of a sustained-release tablet formulation using novel polymer matrices with stability data across temperature and humidity conditions.
        
      Drug Delivery Systems
- Nanoparticle-based delivery (liposomes, polymeric nanoparticles, solid lipid nanoparticles)
- Controlled and sustained release systems
- Targeted drug delivery mechanisms
- Transdermal and transmucosal delivery
- Pulmonary and nasal delivery systems
- Implantable and injectable depot systems
          Typical fit: Characterization of PLGA nanoparticles for controlled release of a hydrophobic drug with in vitro release kinetics and cellular uptake studies.
        
      Pharmaceutical Analysis
- Analytical method development and validation
- Chromatographic techniques (HPLC, UPLC, GC, LC-MS)
- Spectroscopic methods (UV-Vis, IR, NMR)
- Dissolution testing and bioanalytical methods
- Impurity profiling and degradation studies
- Process Analytical Technology (PAT)
          Typical fit: Development and validation of a stability-indicating HPLC method for quantification of an API and its degradation products in pharmaceutical formulations.
        
      Pharmacokinetics & Biopharmaceutics
- ADME (Absorption, Distribution, Metabolism, Excretion) studies
- Bioavailability and bioequivalence assessment
- Pharmacokinetic modeling and simulation
- Drug-drug interaction studies (mechanistic)
- In vitro-in vivo correlation (IVIVC)
- Permeability and solubility enhancement
          Typical fit: Pharmacokinetic modeling of a novel formulation in animal models with correlation to in vitro dissolution profiles for IVIVC establishment.
        
      Secondary Focus Areas
Pharmaceutical Materials Science
- Polymers for pharmaceutical applications
- Biomaterials and biocompatible materials
- Crystallization and polymorphism
- Particle engineering and size reduction
- Material characterization techniques
Manufacturing & Process Technology
- Continuous manufacturing processes
- Pharmaceutical engineering principles
- Granulation, coating, and drying technologies
- Aseptic processing and sterile manufacturing
- Equipment design and optimization
Quality Assurance & Regulatory Science
- Quality control methodologies
- GMP compliance and validation
- Regulatory submission strategies
- Risk assessment in pharmaceutical development
- Pharmacopeial standards and testing
Computational Pharmaceutics
- Molecular modeling for drug-excipient interactions
- In silico prediction of drug properties
- Machine learning for formulation optimization
- Computational fluid dynamics in pharmaceutical processes
- QSAR/QSPR modeling for pharmaceutics
Emerging & Cross-Disciplinary Areas
Article Types & Editorial Priorities
Priority 1
(Fast-Track)
          (Fast-Track)
            Original Research Articles
            Systematic Reviews & Meta-Analyses
            Method Development & Validation
            Technical Notes
          
        Priority 2
(Standard Review)
          (Standard Review)
            Short Communications
            Data Notes
            Perspectives & Commentaries
            Review Articles
          
        Rarely Considered
          
            Case Reports (unless exceptional formulation challenge)
            Opinion Pieces
            Letters to Editor
          
        Editorial Standards & Requirements
Reporting Guidelines
- CONSORT for formulation trials
- PRISMA for systematic reviews
- ARRIVE for animal pharmacokinetic studies
- ICH guidelines for analytical validation
- MIRIBEL for bioequivalence studies
Data & Reproducibility
- Raw data deposition encouraged (Figshare, Dryad)
- Detailed formulation compositions required
- Statistical analysis methods fully described
- Analytical method validation parameters
- Reproducibility statements mandatory
Ethics & Compliance
- IACUC approval for animal studies
- IRB approval if human bioavailability data
- Conflict of interest disclosure
- Funding source transparency
- GMP compliance for manufacturing studies
Preprint & Prior Publication
- Preprints allowed (arXiv, ChemRxiv, bioRxiv)
- Conference abstracts acceptable
- No duplicate publication
- Thesis chapters acceptable with disclosure
- Must declare all prior dissemination
Ready to Submit?
If your research advances pharmaceutical formulation, delivery systems, analytical methods, or manufacturing technology with rigorous experimental design and reproducible data, we want to hear from you.
Submit Your Manuscript 
                                                    
                                             
                        